Displaying items by tag: school of medicine

A UAB study including more than 20,000 ventricular assist device recipients showed that patients diagnosed with familial dilated cardiomyopathy had better clinical outcomes compared with other DCM diagnoses.
This finding suggests utility of treatments before fecal microbial transplants to reduce recipient microbial communities. This would help donor microbial strains dominate in the recipient.
The ADNP/ketamine trial was the first clinical study generated by a information gleaned from the Precision Medicine Institute’s artificial intelligence tool.
This project aims to investigate how the immune system contributes to kidney stones and whether variations in dietary oxalate intake affect immune function.
The summit addressed cervical cancer as a public health problem in Alabama and discussed solutions to devise a roadmap to implement these solutions.
Jim Parsons, an Alabamian and registered organ donor, helped further donation and xenotransplant when his family donated his body upon death for a groundbreaking scientific study conducted at UAB earlier this year.
The gift will advance the use of induced pluripotent stem cells as a potential therapy for Alzheimer’s disease.
Experiments reveal that a catalytic subunit of CK2, called CK2α, is an important regulator of mouse CD8+ T cell activation, metabolic reprogramming and differentiation, both in vitro and in a mouse-infection model by the intracellular pathogen Listeria monocytogenes.
The funding will be used to purchase cutting-edge equipment to assist with high-containment research productivity and pandemic preparedness at UAB.
With the help of the Comprehensive Snakebite Program, Raela Wells is up and moving only two months after a copperhead bit her twice, causing her leg to swell and become immobile — just in time for her wedding.
An internationally recognized clinician and researcher in Parkinson’s disease, UAB’s David Standaert, M.D., Ph.D., has been honored with a lifetime achievement award from the Parkinson’s Association of Alabama.
Direct reprogramming is a potential therapy for heart attack patients. In vitro, TBX20 improved contractility and mitochondrial function of reprogrammed heart muscle cells.
Page 20 of 168